FIRST SUPPLEMENTAL INDENTURESupplemental Indenture • May 6th, 2020 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of November 19, 2019, between HZNP FINANCE LIMITED (the “Guaranteeing Entity”), a subsidiary of Horizon Therapeutics USA, Inc. (formerly known as Horizon Pharma USA, Inc.), a Delaware corporation (the “Issuer”), and U.S. Bank National Association, as trustee under the Indenture referred to below (the “Trustee”).
SECOND SUPPLEMENTAL INDENTURESupplemental Indenture • May 6th, 2020 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
SECOND SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of April 23, 2020, between HORIZON PROPERTIES HOLDING LLC and CURZION PHARMACEUTICALS, INC. (each, a “Guaranteeing Entity”), each a subsidiary of Horizon Therapeutics USA, Inc. (formerly known as Horizon Pharma USA, Inc.), a Delaware corporation (the “Issuer”), and U.S. Bank National Association, as trustee under the Indenture referred to below (the “Trustee”).
